Cargando…
N‐Substituted Nipecotic Acids as (S)‐SNAP‐5114 Analogues with Modified Lipophilic Domains
Potential mGAT4 inhibitors derived from the lead substance (S)‐SNAP‐5114 have been synthesized and characterized for their inhibitory potency. Variations from the parent compound included the substitution of one of its aromatic 4‐methoxy and 4‐methoxyphenyl groups, respectively, with a more polar mo...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317212/ https://www.ncbi.nlm.nih.gov/pubmed/32187815 http://dx.doi.org/10.1002/cmdc.201900719 |
_version_ | 1783550577005821952 |
---|---|
author | Böck, Michael C. Höfner, Georg Wanner, Klaus T. |
author_facet | Böck, Michael C. Höfner, Georg Wanner, Klaus T. |
author_sort | Böck, Michael C. |
collection | PubMed |
description | Potential mGAT4 inhibitors derived from the lead substance (S)‐SNAP‐5114 have been synthesized and characterized for their inhibitory potency. Variations from the parent compound included the substitution of one of its aromatic 4‐methoxy and 4‐methoxyphenyl groups, respectively, with a more polar moiety, including a carboxylic acid, alcohol, nitrile, carboxamide, sulfonamide, aldehyde or ketone function, or amino acid partial structures. Furthermore, it was investigated how the substitution of more than one of the aromatic 4‐methoxy groups affects the potency and selectivity of the resulting compounds. Among the synthesized test substances (S)‐1‐{2‐[(4‐formylphenyl)bis(4‐methoxyphenyl)‐methoxy]ethyl}piperidine‐3‐carboxylic acid, that features a carbaldehyde function in place of one of the aromatic 4‐methoxy moieties of (S)‐SNAP‐5114, was found to have a pIC(50) value of 5.89±0.07, hence constituting a slightly more potent mGAT4 inhibitor than the parent substance while showing comparable subtype selectivity. |
format | Online Article Text |
id | pubmed-7317212 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73172122020-06-30 N‐Substituted Nipecotic Acids as (S)‐SNAP‐5114 Analogues with Modified Lipophilic Domains Böck, Michael C. Höfner, Georg Wanner, Klaus T. ChemMedChem Full Papers Potential mGAT4 inhibitors derived from the lead substance (S)‐SNAP‐5114 have been synthesized and characterized for their inhibitory potency. Variations from the parent compound included the substitution of one of its aromatic 4‐methoxy and 4‐methoxyphenyl groups, respectively, with a more polar moiety, including a carboxylic acid, alcohol, nitrile, carboxamide, sulfonamide, aldehyde or ketone function, or amino acid partial structures. Furthermore, it was investigated how the substitution of more than one of the aromatic 4‐methoxy groups affects the potency and selectivity of the resulting compounds. Among the synthesized test substances (S)‐1‐{2‐[(4‐formylphenyl)bis(4‐methoxyphenyl)‐methoxy]ethyl}piperidine‐3‐carboxylic acid, that features a carbaldehyde function in place of one of the aromatic 4‐methoxy moieties of (S)‐SNAP‐5114, was found to have a pIC(50) value of 5.89±0.07, hence constituting a slightly more potent mGAT4 inhibitor than the parent substance while showing comparable subtype selectivity. John Wiley and Sons Inc. 2020-04-07 2020-05-06 /pmc/articles/PMC7317212/ /pubmed/32187815 http://dx.doi.org/10.1002/cmdc.201900719 Text en © 2020 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Full Papers Böck, Michael C. Höfner, Georg Wanner, Klaus T. N‐Substituted Nipecotic Acids as (S)‐SNAP‐5114 Analogues with Modified Lipophilic Domains |
title | N‐Substituted Nipecotic Acids as (S)‐SNAP‐5114 Analogues with Modified Lipophilic Domains |
title_full | N‐Substituted Nipecotic Acids as (S)‐SNAP‐5114 Analogues with Modified Lipophilic Domains |
title_fullStr | N‐Substituted Nipecotic Acids as (S)‐SNAP‐5114 Analogues with Modified Lipophilic Domains |
title_full_unstemmed | N‐Substituted Nipecotic Acids as (S)‐SNAP‐5114 Analogues with Modified Lipophilic Domains |
title_short | N‐Substituted Nipecotic Acids as (S)‐SNAP‐5114 Analogues with Modified Lipophilic Domains |
title_sort | n‐substituted nipecotic acids as (s)‐snap‐5114 analogues with modified lipophilic domains |
topic | Full Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317212/ https://www.ncbi.nlm.nih.gov/pubmed/32187815 http://dx.doi.org/10.1002/cmdc.201900719 |
work_keys_str_mv | AT bockmichaelc nsubstitutednipecoticacidsasssnap5114analogueswithmodifiedlipophilicdomains AT hofnergeorg nsubstitutednipecoticacidsasssnap5114analogueswithmodifiedlipophilicdomains AT wannerklaust nsubstitutednipecoticacidsasssnap5114analogueswithmodifiedlipophilicdomains |